Home
Nucleus Network

Nucleus Network Market Share Analysis for May 2026

Discover how Nucleus Network protects your personal information and your rights under GDPR, CCPA, and other privacy laws. Learn more today.

Industry: N/A

Domainnucleusnetwork.com.au

Year Founded2003

Employees501 - 1000

Annual Revenue$15M - $25M

Nucleus Network

Nucleus Network (including company regionals)

nucleusnetwork.com.au

See more website traffic and engagement information

Nucleus Network Revenue up to May 2026 is 15M - 25M

revenue generated by Nucleus Network top domains

Nucleus Network top domains revenue over 3 years

Revenue for Nucleus Network top domains

nucleusnetwork.com.au15M - 25M

See more with Sales Intelligence

Total visits to Nucleus Network's top domains

Understand Nucleus Network market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Nucleus Network's top domains

Analyze Nucleus Network engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Nucleus Network's top domains

See how Nucleus Network keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Nucleus Network top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Nucleus Network

These are the website technologies, by industry, used by Nucleus Network top domains

Advertising (11)

Google Adsense

Widget (7)

Twemoji

Conversion & Analytics (5)

Google Analytics

Social (4)

Instagram

More Technologies

7

See all

News & Signals from Nucleus Network

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCosec partners with Nucleus Network Ltd..With Cosec aiding their operations in Australia and partnering with Nucleus Network and 360BioLabs for the clinical trial, this discussion will include client insight into the decisions, challenges and results of selecting Australia as a first-in-human trial location.

NewsNucleus Network Ltd. launched Phase I/II clinical trial of a COVID-19 vaccine candidate on May 26th '20.Nucleus Network today announced the start of its Phase I/II clinical trial of a COVID-19 vaccine candidate at its Melbourne clinic, making it the first human trial for a vaccine in the Southern Hemisphere.

NewsNucleus Network Ltd. partnered with Novavax, Inc on Apr 22nd '20.Australian clinical trials specialist Nucleus Network will partner with US-based biotechnology company Novavax to begin the testing of the NVX-CoV2373 vaccine in the coming weeks.